Regal Rexnord director sells shares, gets RSU grant

REGAL REXNORD CORP director Robin A. Walker-Lee reported both a stock sale and an equity grant.

Rhea-AI Filing Summary

REGAL REXNORD CORP director Robin A. Walker-Lee reported both a stock sale and an equity grant. On 5/11/2026, she sold 1,297 shares of common stock in an open-market transaction at $213.85 per share and then received 923 restricted stock units at no cost.

The grant was made under the 2023 Omnibus Incentive Plan, and the restricted stock units are scheduled to vest on 5/11/2027. After these transactions, her directly held common stock position reported in this filing was 5,503.101 shares.

Insights

Insider trading and equity compensation analyst

Director reports a routine mix of stock sale and RSU grant.

Director Robin A. Walker-Lee sold 1,297 shares of REGAL REXNORD CORP common stock at $213.85 per share and received 923 restricted stock units under the 2023 Omnibus Incentive Plan. The grant vests on 5/11/2027, indicating a long-term incentive structure.

The filing shows a net-sell of 1,297 shares across buy/sell activity, but total direct holdings increased to 6,800.101 shares after including the award. With no derivative positions listed and the sale size modest relative to post-transaction holdings, this appears to be routine compensation and portfolio management.

Insider Trade Summary

Net Seller: 1,297 shares

Net Sell 2 txns

Insider Walker-Lee Robin A

Role Director

Sold 1,297 shs ($277K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	923	$0.00	$0.00
Sale	Common Stock	1,297	$213.85	$277K

Holdings After Transaction: Common Stock — 5,503.101 shares (Direct)

Footnotes (1)

1. F1. Restricted stock units granted to the reporting person under the 2023 Omnibus Incentive Plan. The restricted stock units vest on 5/11/2027.

Key Figures

Shares sold: 1,297 shares Sale price: $213.85 per share RSUs granted: 923 units +4 more

7 metrics

Shares sold 1,297 shares Open-market sale of common stock on May 11, 2026

Sale price $213.85 per share Price for 1,297 sold shares of common stock

RSUs granted 923 units Restricted stock units granted under 2023 Omnibus Incentive Plan

Grant price $0.00 Per-unit grant price for 923 restricted stock units

Post-transaction holdings 6,800.101 shares Direct common stock holdings after award acquisition

Net buy/sell shares -1,297 shares Net buy/sell direction reported as net-sell

RSU vesting date May 11, 2027 Vesting date for 923 restricted stock units

Key Terms

restricted stock units, 2023 Omnibus Incentive Plan, open-market sale, Grant, award, or other acquisition, +1 more

5 terms

restricted stock units financial

"Restricted stock units granted to the reporting person under the 2023 Omnibus Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2023 Omnibus Incentive Plan financial

"Restricted stock units granted to the reporting person under the 2023 Omnibus Incentive Plan."

open-market sale financial

"transaction_action: open-market sale for 1,297 shares of Common Stock."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition for 923 shares."

net-sell financial

"transactionSummary shows netBuySellShares of -1297 and netBuySellDirection net-sell."

FAQ

What did REGAL REXNORD (RRX) director Robin A. Walker-Lee report in this Form 4?

She reported an open-market sale of 1,297 REGAL REXNORD common shares at $213.85 each and the receipt of 923 restricted stock units as an equity award, with her direct holdings rising to 6,800.101 shares after these transactions.

How many REGAL REXNORD (RRX) shares did the director sell and at what price?

Robin A. Walker-Lee sold 1,297 shares of REGAL REXNORD common stock in an open-market transaction at a price of $213.85 per share. This transaction is coded as a sale (code S) of non-derivative common stock.

What equity award did the REGAL REXNORD (RRX) director receive in this filing?

She received 923 restricted stock units of REGAL REXNORD common stock at a grant price of $0.00. The award was granted under the 2023 Omnibus Incentive Plan and is scheduled to vest in full on May 11, 2027.

What are Robin A. Walker-Lee’s REGAL REXNORD (RRX) holdings after these Form 4 transactions?

After the reported sale and restricted stock unit grant, Robin A. Walker-Lee’s directly held REGAL REXNORD common stock position in this filing is 6,800.101 shares. The derivative section shows no remaining options or other derivative securities reported.

Is the net effect of this REGAL REXNORD (RRX) Form 4 a buy or a sell?

Across buy and sell activity, the filing reflects a net-sell of 1,297 shares, driven by the open-market sale. However, the concurrent grant of 923 restricted stock units increases her long-term equity-based compensation exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 04:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walker-Lee Robin A

(Last) (First) (Middle)

111 WEST MICHIGAN STREET

(Street)

MILWAUKEE WISCONSIN 53203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
REGAL REXNORD CORP [ RRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/11/2026		A		923(1)	A	$0	6,800.101	D
Common Stock	05/11/2026		S		1,297	D	$213.85	5,503.101	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units granted to the reporting person under the 2023 Omnibus Incentive Plan. The restricted stock units vest on 5/11/2027.

Remarks:

	/s/ Molly Johnson, as Power of Attorney	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)